Chemed Corporation $CHE Shares Sold by California State Teachers Retirement System

California State Teachers Retirement System decreased its stake in shares of Chemed Corporation (NYSE:CHE - Free Report) by 2.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,348 shares of the company's stock after selling 484 shares during the period. California State Teachers Retirement System owned about 0.13% of Chemed worth $7,613,918 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of CHE. HB Wealth Management LLC bought a new position in shares of Chemed in the 2nd quarter valued at about $542,000. Compass Financial Management LLC bought a new position in Chemed during the second quarter worth about $52,000. Syon Capital LLC purchased a new stake in Chemed in the second quarter worth approximately $235,000. denkapparat Operations GmbH purchased a new stake in Chemed in the second quarter worth about $638,000. Finally, Nykredit A S bought a new stake in shares of Chemed in the 2nd quarter valued at about $277,000. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Buying and Selling

In other news, EVP Spencer S. Lee sold 1,000 shares of Chemed stock in a transaction on Friday, August 21st. The shares were sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the sale, the executive vice president directly owned 13,912 shares of the company's stock, valued at approximately $7,526,948.48. The trade was a 6.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $541.16, for a total value of $1,082,320.00. Following the transaction, the chief executive officer directly owned 70,418 shares in the company, valued at approximately $38,107,404.88. The trade was a 2.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 5,190 shares of company stock worth $2,803,460. Corporate insiders own 3.33% of the company's stock.

Chemed Trading Down 1.1%

CHE traded down $5.58 during trading hours on Tuesday, reaching $508.71. The company's stock had a trading volume of 71,245 shares, compared to its average volume of 209,063. The business's 50-day moving average is $521.41 and its 200-day moving average is $453.53. The stock has a market cap of $6.65 billion, a PE ratio of 25.55, a P/E/G ratio of 1.95 and a beta of 0.51. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $557.00. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. During the same period last year, the business posted $4.27 EPS. Chemed's quarterly revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities research analysts predict that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were paid a $0.70 dividend. The ex-dividend date of this dividend was Monday, August 17th. This is a boost from Chemed's previous quarterly dividend of $0.60. This represents a $2.80 annualized dividend and a yield of 0.6%. Chemed's payout ratio is currently 14.06%.

Wall Street Analyst Weigh In

Several research firms have issued reports on CHE. Wall Street Zen raised shares of Chemed from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 1st. Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, July 17th. Oppenheimer raised their target price on shares of Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a research note on Friday, July 31st. Bank of America restated a "neutral" rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Royal Bank Of Canada increased their target price on shares of Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $530.75.

Chemed Profile

Chemed Corporation is a diversified holding company that operates businesses in the healthcare and residential and commercial services industries. Its primary operations are conducted through VITAS Healthcare and Roto-Rooter.

VITAS Healthcare provides hospice and palliative care for patients with advanced illnesses. Its services are delivered in patients' homes, hospice residences, nursing facilities, hospitals and other care settings, primarily throughout the United States. Care is provided by interdisciplinary teams that may include physicians, nurses, hospice aides, social workers and chaplains.

Roto-Rooter provides plumbing and drain-cleaning services, as well as water cleanup and related services for residential and commercial customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.